Welcome to the e-CCO Library!

P121: Antimicrobial antibodies and inflammatory markers are present in the serum of patients with IBD years before diagnosis and can predict disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Torres J.*1, Wang P.2, Princen F.3, Stockfisch T.3, Petralia F.2, Choung R.S.4, Telesco S.5, Strauss R.5, Porter C.6, Murray J.4, Riddle M.6, Colombel J.-F.1

Created: Wednesday, 20 February 2019, 10:36 AM
P121: Characterising and managing issues with food-related quality of life in inflammatory bowel disease: a qualitative study of patients and healthcare professionals
Year: 2018
Source: ECCO '18 Vienna
Authors:

W. Czuber-Dochan1*, M. Morgan2, M. Lomer1, J.O. Lindsay3, G. Robert4, K. Whelan1

Created: Thursday, 21 February 2019, 9:14 AM
P121: Clinicomic profiles new feature patterns based on a simplified location classification for Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hu, W.(1)*;Liang, X.(2);Luo, J.(1);Li, P.(1);Shen, K.(3);Li, J.(4);Li, S.(5);Xin, J.(1);Jiang, J.(1);Shi, D.(1);Wang, X.(6);Xu, D.(6);Yu, Q.(6);Zhang, H.(6);Zhang, X.(7);Song, X.(8);Guo, H.(8);Ge, Q.(9);Chen, Y.(9);Chen, X.(10);Chen, Y.(6);Li, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P121: Correlation between histological activity and endoscopy in patients with UC, seen in a tertiary centre of gastroenterology in Romania
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Cojocaru*1, C. Gheorghe2, L. Gheorghe2

Created: Friday, 22 February 2019, 9:41 AM
P121: Patients’ point of view regarding acceptability and usefulness of inflammatory bowel diseases monitoring tools: results from a nationwide multicentre study (the ACCEPT study)
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Buisson*1, 2, F. Gonzalez3, F. Poullenot4, S. Nancey5, E. Sollellis1, M. Fumery6, B. Pariente7, M. Flamant8, A. Bourreille9, G. Bonnaud10, S. Mathieu11, A. Thevenin12, M. Duruy13, J. FILIPPI14, F. L’hopital15, F. Luneau16, V. Michalet15, J. Genès15, A. Achim17, E. Cruzille15, G. Bommelaer1, 2, D. Laharie18, L. Peyrin-Biroulet19, B. Pereira20, M. Nachury21, G. Bouguen22

Created: Friday, 22 February 2019, 9:49 AM
P121: Second-Line Biologic Therapy Persistence in a Multicentre Cohort of Inflammatory Bowel Disease Patients
Year: 2022
Source: ECCO'22
Authors: Doherty, J.(1);Stack, R.(2);O Morain, N.(2);Corcoran, R.(3);Ryan, B.(4);Doherty, G.(2);Mc Namara, D.(4);Kevans, D.(4);
Created: Friday, 11 February 2022, 3:52 PM
P121: The study of the hypercoagulable state in Crohn disease: Results of a prospective comparative study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Serghini, M.(1);Ben Youssef, H.(1);Laabidi, A.(1);Ben Mustapha, N.(1);Hafi, M.(1);fekih, M.(1);Boubaker, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P122 High correlation between faecal calprotectin and a Novel Integral Index for evaluating disease activity in ulcerative colitis patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.K. Yamamoto-Furusho MD, PhD1, E.A. Mendieta-Escalante2

Created: Thursday, 30 January 2020, 10:12 AM
P122: External validation of the Picasso Histological Remission Index (PHRI) to assess endoscopic and histological remission and predict long-term outcome in Ulcerative Colitis: A multicentre prospective study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: ParigiMD, T.L.(1)*;Cannatelli, R.(2);Nardone, O.M.(3);Zammarchi, I.(4);Shivaji, U.(1);Furfaro, F.(5);Zardo, D.(6);Spaggiari, P.(7);Del Sordo, R.(8);Setti, O.(9);Majumder, S.(1);Smith, S.C.L.(1);Ghosh, S.(10);Danese, S.(5);Armuzzi, A.(11);Villanacci, V.(9);Iacucci, M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P122: Longitudinal follow-up of body mass index as a predictor for severe disease course in children with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Yerushalmy-Feler*1,2, S. Cohen1,2

Created: Friday, 22 February 2019, 9:41 AM
P122: Low Risk of new dysplastic lesions during inflammatory bowel disease surveillance with dye-cromoendoscopy: a multicenter population-based retrospective study
Year: 2022
Source: ECCO'22
Authors: Saiz Chumillas, R.M.(1);Alba, L.(1);Gonzalez-Lama, Y.(2);Velayos, B.(3);Suarez, P.(4);Maroto-Martin, C.(5);Nuñez, A.(6);Hernandez, L.(7);Relea, L.(2);Fernandez-Salazar, L.(3);Sierra-Ausin, M.(4);Barrio, J.(5);Muñoz, F.(6);Arias, L.(1);Sicilia, B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P122: Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
Year: 2021
Source: ECCO'21 Virtual
Authors: Levartovsky, A.(1);Barash, Y.(2,3);Ben-Horin, S.(1);Ungar, B.(1);Klang, E.(2,3);Soffer, S.(3);Amitai, M.M.(2);Kopylov, U.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P122: Magnetic resonance index of activity (MaRIA) and Clermont score are two MRI indices which are highly and equally effective in detecting mucosal healing in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buisson A.*1,2, Pereira B.3, Goutte M.1,2, Reymond M.1, Allimant C.1, Bommelaer G.1,2, Hordonneau C.4

Created: Wednesday, 20 February 2019, 10:36 AM
P122: Role of diffusion-weighted imaging in MRI-enterography for the evaluation of surgical risk in patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Testa*1, A. Rispo1, P. Mainenti2, D. Musto1, N. Imperatore1, M. Rea1, O.M. Nardone1, M. L. Taranto1, F. Castiglione1

Created: Friday, 22 February 2019, 9:49 AM
P122: Vitamin D activates human intestinal fibroblasts
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Gisbert-Ferrándiz1*, P. Salvador1, D.C. Macias-Ceja2, J. Cosín-Roger2, D. Ortiz-Masiá3,4, F. Navarro-Vicente5, S. Calatayud1,4, C. Hernández2, M.D. Barrachina1,4

Created: Thursday, 21 February 2019, 9:14 AM
P123 Sarcopenia is a predictor for severe disease course in paediatric inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Atlan1,2, L.T. Pratt1,2, S. Cohen2,3, S. Shiran1,2, A. Yerushalmy-feler2,3

Created: Thursday, 30 January 2020, 10:12 AM
P123: Characteristics of small bowel involvement and association with clinical outcome in patients with Crohn's disease
Year: 2022
Source: ECCO'22
Authors: Yoon, H.(1);Park, J.(1);Kim, H.Y.(2);Lee, Y.J.(2);Shin, C.M.(1);Park, Y.S.(1);Kim, N.(1);Lee, D.H.(1);
Created: Friday, 11 February 2022, 3:52 PM
P123: Development of an end-to-end Mayo endoscopic score machine learning algorithm for use in clinical trials of ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vieira, M.(1)*;Mishkin, D.S.(2);Gaither, K.W.(3);Safran, M.(4);Dashuta, A.(4);Tarakanov, A.(4);Zfira, L.(4);Fuerst, T.(5);
Created: Friday, 14 July 2023, 10:48 AM
P123: MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buisson A.*1,2, Hordonneau C.3, Goutorbe F.1,4, Allimant C.1, Goutte M.1,2, Reymond M.1, Pereira B.5, Bommelaer G.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P123: Significance of serological markers in the disease course of ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. Kovacs*1, N. Sipeki1, K. Palatka1, I. Altorjay1, K. Fechner2, 
G. L. Norman3, Z. Shums3, G. Veres4, P. L. Lakatos5, M. Papp1

Created: Friday, 22 February 2019, 9:49 AM